Crescent Capital BDC, Inc. (NASDAQ:CCAP – Get Rating) CFO Gerhard Lombard bought 700 shares of the company’s stock in a transaction on Monday, May 23rd. The stock was bought at an average cost of $16.84 per share, for a total transaction of $11,788.00. Following the completion of the acquisition, the chief financial officer now directly owns 21,674 shares of the company’s stock, valued at approximately $364,990.16. The purchase was disclosed in a legal filing with the SEC, which can be accessed through this link.
Gerhard Lombard also recently made the following trade(s):
- On Thursday, May 12th, Gerhard Lombard purchased 1,000 shares of Crescent Capital BDC stock. The shares were acquired at an average cost of $16.89 per share, for a total transaction of $16,890.00.
Crescent Capital BDC stock opened at $17.59 on Friday. The stock has a market cap of $543.36 million, a PE ratio of 6.51, a price-to-earnings-growth ratio of 0.88 and a beta of 0.88. The company has a debt-to-equity ratio of 0.96, a quick ratio of 0.80 and a current ratio of 0.80. Crescent Capital BDC, Inc. has a one year low of $16.55 and a one year high of $21.48. The stock has a fifty day moving average of $17.62 and a 200 day moving average of $17.96.
The business also recently declared a quarterly dividend, which will be paid on Friday, July 15th. Shareholders of record on Thursday, June 30th will be given a $0.41 dividend. This represents a $1.64 dividend on an annualized basis and a yield of 9.32%. The ex-dividend date of this dividend is Wednesday, June 29th. Crescent Capital BDC’s payout ratio is 60.74%.
CCAP has been the topic of a number of research analyst reports. Bank of America initiated coverage on Crescent Capital BDC in a report on Monday, January 31st. They set a “buy” rating and a $19.50 price target on the stock. Wells Fargo & Company lowered their price target on Crescent Capital BDC from $19.50 to $18.50 and set an “overweight” rating on the stock in a report on Monday, April 25th. Finally, Zacks Investment Research cut Crescent Capital BDC from a “hold” rating to a “sell” rating in a research report on Tuesday, April 26th. One research analyst has rated the stock with a sell rating, one has assigned a hold rating and three have given a buy rating to the stock. According to data from MarketBeat, the company currently has an average rating of “Hold” and an average price target of $19.70.
A number of institutional investors and hedge funds have recently modified their holdings of the business. Royal Bank of Canada increased its position in Crescent Capital BDC by 157.0% in the first quarter. Royal Bank of Canada now owns 33,928 shares of the company’s stock worth $604,000 after buying an additional 20,728 shares in the last quarter. Captrust Financial Advisors increased its position in Crescent Capital BDC by 797.8% in the first quarter. Captrust Financial Advisors now owns 62,726 shares of the company’s stock worth $1,117,000 after buying an additional 55,739 shares in the last quarter. UBS Group AG increased its position in Crescent Capital BDC by 48.2% in the first quarter. UBS Group AG now owns 6,645 shares of the company’s stock worth $118,000 after buying an additional 2,160 shares in the last quarter. Ares Management LLC increased its position in Crescent Capital BDC by 54.0% in the first quarter. Ares Management LLC now owns 657,838 shares of the company’s stock worth $11,710,000 after buying an additional 230,593 shares in the last quarter. Finally, Sun Life Financial Inc. increased its position in Crescent Capital BDC by 62.1% in the first quarter. Sun Life Financial Inc. now owns 1,076,654 shares of the company’s stock worth $19,164,000 after buying an additional 412,640 shares in the last quarter. Institutional investors and hedge funds own 54.76% of the company’s stock.
Crescent Capital BDC Company Profile (Get Rating)
Crescent Capital BDC, Inc is a business development company. The fund focuses on originating and investing in the debt of middle market companies. It typically focuses on companies based in United States.
- Get a free copy of the StockNews.com research report on Crescent Capital BDC (CCAP)
- These Are the Three (3) Most Upgraded Stocks For Q2
- MarketBeat: Week in Review 5/23 – 5/27
- Short Sellers Provide Entry Into Hibbet, Inc At Rock Bottom Prices
- Affirm Stock Has Affirmed a Bottom
- Airbnb: Bold Competitive Threats & A New World of Travel
Receive News & Ratings for Crescent Capital BDC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Crescent Capital BDC and related companies with MarketBeat.com's FREE daily email newsletter.